NEURAXIS INC

NRXSNYSE AMERICAN

🏆 #3087 by market capEarnings Aug 11 · PreUS Equity

$6.35▼ $0.48 (−7.57%)

Live

1h—

24h▼ 7.6%

7d—

14d—

30d—

1y—

🏦Market Cap

$79M

Small Cap

📈Revenue Growth (YoY)

+45.9%

High Growth

📊Gross Margin

85.0%

High

💵FCF Margin

—

⚖️P/S Ratio

20.0x

Expensive

Otter Score

Weak

No chart data available for NRXS.

Trading Snapshot

Day Range: $6.26 – $6.45
52-Week Range: $2.20 – $9.33
Volume: $3.58B
Avg Volume: $4.65B
Shares Outstanding: 12.4M
Next Earnings: Sep 18, 2026

Fundamentals Snapshot

Annual Revenue: $4M
Last Q Revenue: $2M
P/E Ratio: —
P/S Ratio: 20.0x
EPS (TTM): $-0.74
Dividend Yield: —

Why Investors Own NRXS

✓High-growth profile — revenue up +55.0% YoY with expanding US Equity exposure.
✓Healthy economics — 77% gross margin and 17% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$4M▲ +54.0% YoY

Gross Margin (TTM)

76.8%▲ +3.6% YoY

Operating Income (TTM)

$1M▲ +54.0% YoY

Free Cash Flow (TTM)

$603,209▲ +54.0% YoY

About NEURAXIS INC

NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.

🦦